Collegium Pharmaceutical (COLL) Free Cash Flow (2016 - 2026)
Collegium Pharmaceutical has reported Free Cash Flow over the past 10 years, most recently at $123.0 million for Q4 2025.
- For Q4 2025, Free Cash Flow rose 43.84% year-over-year to $123.0 million; the TTM value through Dec 2025 reached $329.0 million, up 60.65%, while the annual FY2025 figure was $329.0 million, 60.65% up from the prior year.
- Free Cash Flow for Q4 2025 was $123.0 million at Collegium Pharmaceutical, up from $78.2 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $123.0 million in Q4 2025 and troughed at -$25.4 million in Q1 2022.
- A 5-year average of $51.6 million and a median of $58.0 million in 2024 define the central range for Free Cash Flow.
- Biggest five-year swings in Free Cash Flow: tumbled 226.22% in 2022 and later surged 946.56% in 2025.
- Year by year, Free Cash Flow stood at $35.7 million in 2021, then surged by 83.24% to $65.4 million in 2022, then grew by 12.35% to $73.5 million in 2023, then grew by 16.45% to $85.5 million in 2024, then surged by 43.84% to $123.0 million in 2025.
- Business Quant data shows Free Cash Flow for COLL at $123.0 million in Q4 2025, $78.2 million in Q3 2025, and $73.1 million in Q2 2025.